CITIC Securities: Short-term white horse style may be dominated by stages due to compensatory growth and repair. CITIC Securities Research Report pointed out that looking forward to 2025, we expect that the market style will gradually switch from individual investors to institutional investors, and ETF will become an important configuration tool. We believe that the construction of ETF portfolio should mainly depend on the judgment of style rotation and timing. We believe that in the short term, Politburo meeting of the Chinese Communist Party and the Central Economic Work Conference will once again confirm the policy inflection point, which is expected to boost institutional investors' risk appetite, and the white horse style may prevail in stages due to compensatory growth and repair. However, in the large-cycle environment, it is still unable to meet the conditions for the continued dominance of white horse stocks, and it is necessary to continue to observe the price signals and policies.South Korea will take additional market stabilization measures when necessary.Korean media: South Korean President Yin Xiyue tried to appoint a new defense minister. The East Asia Daily did not explain that the source reported that South Korean President Yin Xiyue tried to appoint a new defense minister, which indicated that Yin Xiyue might resume his job, although he said last week that he would let the ruling party decide how to stabilize future state affairs and his term of office. After making a public speech on Thursday, Yin Xiyue approved the 42 agendas adopted at this week's cabinet meeting. This shows that Yin Xiyue may exercise the presidential power immediately after he hinted in his speech that he had no intention of stepping down.
Guotai Junan: It is suggested that the beauty care sector with product and channel changes and flexibility should be optimized from the bottom up. Guotai Junan said that after the pressure of consumption in 2022 and the destocking of consumers in 2023, the beauty consumption will return to the normal purchase cycle in 2024, and the industry prosperity will improve month-on-month, and the double-digit growth of online beauty will be achieved. However, after the channel dividend subsided, the platform traffic and price competition became fierce, and the brand differentiation further intensified. Relying on the product innovation and channel operation ability brought by organizational efficiency, the performance of domestic products in the head is still bright, and the rise of new domestic products has spread from beauty cosmetics to personal care. Looking forward to 2025, the market risk appetite will be significantly restored. Because of its many changes and the rising trend of domestic products as a whole, the American nursing sector has obvious growth attributes and significantly benefited from its style. Brand differentiation in the fundamental dimension has intensified, and it is suggested that the flexible target with product and channel changes should be optimized from bottom to top.People's Daily: Ensure that artificial intelligence is always a "friend". At present, the ability of artificial intelligence is comparable to that of human brain in many aspects, but it cannot accurately distinguish right from wrong in terms of value. This means that it is necessary to strengthen the supervision and regulation of artificial intelligence from many aspects. In recent years, many countries, including China, have introduced artificial intelligence development plans, management methods and supervision principles, precisely to ensure that technology truly serves people and benefits society. No matter how far artificial intelligence develops, it all comes from human design and is an extension of human wisdom. Artificial intelligence is doing more and more work and becoming more and more intelligent. We must take precautions to ensure that it is always a "friend".The leading enterprises in the quantum science and technology sector are competing for layout. Recently, the quantum science and technology sector has been active. Since September 24, the concept index of the straight flush quantum science and technology has risen by more than 60%, and the stock prices of many stocks have doubled. Among A-share listed companies, many companies including China Mobile, China Telecom, Guo Dun Quantum, Hexin Instrument, Guoxin Technology and Geer Software have already laid out in the field of quantum technology. In terms of future market potential, ICVTA&K, a scientific and technological consulting organization, predicts that in 2023, the overall market size of the global quantum industry may reach 7.24 billion US dollars. However, the current quantum technology industry is still in the stage of research and development and industrial exploration. Taking quantum computing as an example, Guo Dun Quantum said in a survey conducted by an organization on November 15th that quantum computers have only achieved quantum superiority in some specific problems at present, and it is estimated that it will take about 5 to 10 years to surpass classical computing power in practical and valuable problems in the future. (Economic Information Daily)
Pfizer announced an increase in its quarterly dividend, and American pharmaceutical giant Pfizer said on Thursday that it would increase its quarterly dividend by 2.4%, from 42 cents to 43 cents per share. The new dividend is equivalent to $1.72 per year, which means that the annual yield is about 6.8%. Albert Bourla, CEO of Pfizer, said that the dividend increase highlighted the company's strong financial performance, execution and commitment to return capital to shareholders.China Seismological Network automatically measured that an earthquake of magnitude 4.4 occurred near Yuli County, Bayinguoleng Prefecture, Xinjiang at 07: 22 on December 13th (40.93 degrees north latitude and 84.13 degrees east longitude), and the final result was subject to the official quick report.Yingsi Intelligent announced that it had received a milestone payment of $10 million from Exelixis. On December 13th, Yingsi Intelligent, a biomedical technology company, announced that based on the progress made in the clinical stage of XL309(ISM3091) project, the company had recently received the first clinical milestone payment from Exelixis, with a total amount of $10 million.
Strategy guide
12-14
Strategy guide
Strategy guide
12-14
Strategy guide